Alexion shoots down 'proactive' sale demand from activist investor

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Dec 6, 2019 at 10:52 AM.

  1. cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,990
    Likes Received:
    3
    via Alexion has withstood its fair share of gales in recent years after a wholesale shakeup at the top and a shift toward an M&A-focused strategy underway. Now, despite one activist investor's call for a "proactive" sale, Alexion's board has decided to stay the course.

    article source